Propolis for Patients With Chronic Kidney Disease.
Launched by UNIVERSIDADE FEDERAL FLUMINENSE · May 28, 2020
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
Chronic kidney disease (CKD) has chronic systemic inflammation as an important component of multifactorial origin, a factor related to both the progression and outcomes of CKD, being involved in all causes of mortality in these patients, such as cardiovascular disease. In this context, some nutritional strategies have been proposed as an adjuvant therapeutic alternative to modulate inflammation, starting from the consolidated knowledge of the role of nutrients and bioactive compounds on the expression of genes related to inflammation and oxidative stress, factors that feed on each other. In...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Aged 18 years or older
- • - with fistula arteriovenous
- Exclusion Criteria:
- • Patients pregnant
- • Smokers
- • Using antibiotics in the last three months
- • Using antioxidant supplements as antioxidant vitamins, probiotic, prebiotic, symbiotic and antibiotics in the last three months
- • Clinical diagnosis of infectious diseases
- • Clinical diagnosis of Cancer
- • Clinical diagnosis of AIDS - for PD patients - no peritonitis
About Universidade Federal Fluminense
Universidade Federal Fluminense (UFF) is a prestigious Brazilian public university renowned for its commitment to academic excellence and innovation in research. As a clinical trial sponsor, UFF leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The institution fosters collaboration between researchers, healthcare professionals, and industry partners, ensuring rigorous ethical standards and adherence to regulatory requirements in the conduct of clinical trials. UFF's dedication to scientific inquiry and community health positions it as a leading contributor to the advancement of clinical research in Brazil and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Niterói, Rio De Janeiro, Brazil
Patients applied
Trial Officials
Denise Mafra, phd
Principal Investigator
Universidade Federal Fluminense
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials